Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

InMed Pharmaceuticals Inc.

(Exact Name of Registrant as Specified in its Charter)

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered(1)

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price(2)

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Shares, without par

value

457(c)

2,050,000

$1.17

$2,398,500

0.0000927

$222.34

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Total Offering Amounts

$2,398,500

$222.34

Total Fees Previously Paid

$0.00

Total Fee Offsets

$0.00

Net Fee Due

$222.34

(1) This Registration Statement also includes such additional number of common shares (without par value) of InMed Pharmaceuticals Inc. (“Common Shares”), issuable as may be required in the event of a stock split, stock dividend or similar transaction in accordance with Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”).

(2) Estimated solely for purposes of calculating the registration fee in accordance with Rules 457(c) of the Securities Act, based upon the average of the high and low prices of Common Shares on February 1, 2022, which date is within five business days prior to filing, as reported on the Nasdaq Capital Market, of $1.17.